vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and WYNDHAM HOTELS & RESORTS, INC. (WH). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $334.0M, roughly 1.5× WYNDHAM HOTELS & RESORTS, INC.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -18.0%, a 24.8% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -76.3%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -4.6%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Wyndham Hotels & Resorts, Inc., is an American hospitality company based in Parsippany, New Jersey, United States. It describes itself as the largest hotel franchisor in the world, with 9,100 locations.
MD vs WH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $334.0M |
| Net Profit | $33.7M | $-60.0M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | — |
| Net Margin | 6.8% | -18.0% |
| Revenue YoY | -1.7% | -76.3% |
| Net Profit YoY | 10.5% | -170.6% |
| EPS (diluted) | $0.40 | $-0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $334.0M | ||
| Q4 25 | $493.8M | $334.0M | ||
| Q3 25 | $492.9M | $382.0M | ||
| Q2 25 | $468.8M | $397.0M | ||
| Q1 25 | $458.4M | $316.0M | ||
| Q4 24 | $502.4M | $336.0M | ||
| Q3 24 | $511.2M | $396.0M | ||
| Q2 24 | $504.3M | $367.0M |
| Q1 26 | — | $-60.0M | ||
| Q4 25 | $33.7M | $-60.0M | ||
| Q3 25 | $71.7M | $105.0M | ||
| Q2 25 | $39.3M | $87.0M | ||
| Q1 25 | $20.7M | $61.0M | ||
| Q4 24 | $30.5M | $85.0M | ||
| Q3 24 | $19.4M | $102.0M | ||
| Q2 24 | $-153.0M | $86.0M |
| Q1 26 | — | — | ||
| Q4 25 | 9.9% | -11.4% | ||
| Q3 25 | 13.8% | 46.6% | ||
| Q2 25 | 12.8% | 37.8% | ||
| Q1 25 | 7.0% | 35.4% | ||
| Q4 24 | 7.8% | 38.4% | ||
| Q3 24 | 6.6% | 43.2% | ||
| Q2 24 | -31.3% | 39.5% |
| Q1 26 | — | -18.0% | ||
| Q4 25 | 6.8% | -18.0% | ||
| Q3 25 | 14.5% | 27.5% | ||
| Q2 25 | 8.4% | 21.9% | ||
| Q1 25 | 4.5% | 19.3% | ||
| Q4 24 | 6.1% | 25.3% | ||
| Q3 24 | 3.8% | 25.8% | ||
| Q2 24 | -30.3% | 23.4% |
| Q1 26 | — | $-0.80 | ||
| Q4 25 | $0.40 | $-0.77 | ||
| Q3 25 | $0.84 | $1.36 | ||
| Q2 25 | $0.46 | $1.13 | ||
| Q1 25 | $0.24 | $0.78 | ||
| Q4 24 | $0.37 | $1.06 | ||
| Q3 24 | $0.23 | $1.29 | ||
| Q2 24 | $-1.84 | $1.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $64.0M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $468.0M |
| Total Assets | $2.2B | $4.2B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $64.0M | ||
| Q4 25 | $375.2M | $64.0M | ||
| Q3 25 | $340.1M | $70.0M | ||
| Q2 25 | $224.7M | $50.0M | ||
| Q1 25 | $99.0M | $48.0M | ||
| Q4 24 | $229.9M | $103.0M | ||
| Q3 24 | $103.8M | $72.0M | ||
| Q2 24 | $19.4M | $70.0M |
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | $2.5B | ||
| Q3 25 | $577.2M | $2.6B | ||
| Q2 25 | $583.9M | $2.5B | ||
| Q1 25 | $590.5M | $2.5B | ||
| Q4 24 | $597.1M | $2.4B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.4B |
| Q1 26 | — | $468.0M | ||
| Q4 25 | $865.9M | $468.0M | ||
| Q3 25 | $890.7M | $583.0M | ||
| Q2 25 | $833.8M | $570.0M | ||
| Q1 25 | $789.2M | $579.0M | ||
| Q4 24 | $764.9M | $650.0M | ||
| Q3 24 | $732.5M | $583.0M | ||
| Q2 24 | $706.5M | $623.0M |
| Q1 26 | — | $4.2B | ||
| Q4 25 | $2.2B | $4.2B | ||
| Q3 25 | $2.2B | $4.3B | ||
| Q2 25 | $2.1B | $4.3B | ||
| Q1 25 | $2.0B | $4.2B | ||
| Q4 24 | $2.2B | $4.2B | ||
| Q3 24 | $2.1B | $4.2B | ||
| Q2 24 | $2.0B | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | 5.37× | ||
| Q3 25 | 0.65× | 4.43× | ||
| Q2 25 | 0.70× | 4.44× | ||
| Q1 25 | 0.75× | 4.29× | ||
| Q4 24 | 0.78× | 3.72× | ||
| Q3 24 | — | 4.19× | ||
| Q2 24 | — | 3.83× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $367.0M |
| Free Cash FlowOCF − Capex | — | $168.0M |
| FCF MarginFCF / Revenue | — | 50.3% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $437.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $367.0M | ||
| Q4 25 | $114.1M | $152.0M | ||
| Q3 25 | $137.3M | $86.0M | ||
| Q2 25 | $137.2M | $70.0M | ||
| Q1 25 | $-117.5M | $59.0M | ||
| Q4 24 | $133.0M | $134.0M | ||
| Q3 24 | $91.8M | $79.0M | ||
| Q2 24 | $107.0M | $1.0M |
| Q1 26 | — | $168.0M | ||
| Q4 25 | — | $136.0M | ||
| Q3 25 | — | $75.0M | ||
| Q2 25 | — | $58.0M | ||
| Q1 25 | — | $52.0M | ||
| Q4 24 | — | $109.0M | ||
| Q3 24 | — | $71.0M | ||
| Q2 24 | — | $-6.0M |
| Q1 26 | — | 50.3% | ||
| Q4 25 | — | 40.7% | ||
| Q3 25 | — | 19.6% | ||
| Q2 25 | — | 14.6% | ||
| Q1 25 | — | 16.5% | ||
| Q4 24 | — | 32.4% | ||
| Q3 24 | — | 17.9% | ||
| Q2 24 | — | -1.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.8% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 0.82× | ||
| Q2 25 | 3.49× | 0.80× | ||
| Q1 25 | -5.66× | 0.97× | ||
| Q4 24 | 4.36× | 1.58× | ||
| Q3 24 | 4.72× | 0.77× | ||
| Q2 24 | — | 0.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
WH
| Fee-related and other revenues | $334.0M | 100% |
| Management and other fees | $2.0M | 1% |
